NewsBenzingaBTIG, 컬리넌 테라퓨틱스에 대해 매수 의견 재확인 및 목표주가 40달러 유지 BTIG, 컬리넌 테라퓨틱스에 대해 매수 의견 재확인 및 목표주가 40달러 유지 Benzinga 2026.09.25 09:49 (GMT+0) Open on Benzinga Other news TechCrunch Mobility: Rivian’s next act DWF Labs: Market Has Not Yet Priced in AI-Crypto Convergence; DePIN and Payments May Become Beneficiaries Musk: X usage hits all-time high Former Mt. Gox CEO reveals plans to develop low-cost device to detect spy implants in Ledger HPE Stock Alert: Barclays Just Delivered A Stark Warning After 145% Rally "AI Stock Guru" Leopold's fund to disclose Q3 holdings on Nov 16, once saw 67% monthly drawdown amid AI stock crash
DWF Labs: Market Has Not Yet Priced in AI-Crypto Convergence; DePIN and Payments May Become Beneficiaries
"AI Stock Guru" Leopold's fund to disclose Q3 holdings on Nov 16, once saw 67% monthly drawdown amid AI stock crash
